Clopidogrel: all 338 studies that test it

Page 2 of 4. Open to participants first (32), then studies with results posted, then the rest; newest registration first within each.

• Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen OvaleCompletedNCT05546320Phase 2
• Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics ProfileCompletedNCT05516784Phase 4
• Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted CoilingCompletedNCT05257824Phase 4
• Optimal Dosage of Ticagrelor in Korean Patients With AMIStatus unknownNCT05210595Phase 4
• Bioequivalence Study of Clopid® (Clopidogrel) 75 mg Tablet and Plavix® 75 mg Tablet After Oral Administration to Healthy Adult Subjects Under Fasting ConditionCompletedNCT05186129Phase 1
• PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 MetabolizersCompletedNCT05162053Phase 1
• Effects of Edoxaban on Platelet AggregationCompletedNCT05122455Phase 2/3
• The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission AggregometryCompletedNCT04822363Early Phase 1
• Drug Interaction Study of MGL-3196 With ClopidogrelCompletedNCT04671069Phase 1
• VerifyNow to Optimise Platelet Inhibition in Coronary Acute SyndromeCompletedNCT04654052Phase 4
• SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3CompletedNCT04418479Phase 4
• Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial InfarctionCompletedNCT04369534Phase 4
• Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19CompletedNCT04368377Phase 2
• Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.TerminatedNCT04333407Not applicable
• Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male VolunteersCompletedNCT04171687Phase 1
• Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid StentingStatus unknownNCT04091074Phase 1
• Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery DiseaseCompletedNCT04001894Phase 4
• Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACSStatus unknownNCT03775746Phase 4
• Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina PatientsCompletedNCT03759067Not applicable
• A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy SubjectsCompletedNCT03698513Phase 1
• Low-dose of Ticagrelor and Standard-dose Clopidogrel on Platelet Effects in Chinese Patients With Stable CAD.CompletedNCT03679091Phase 4
• Antiplatelet vs R-tPA for Acute Mild Ischemic StrokeCompletedNCT03661411Phase 4
• Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial AneurysmCompletedNCT03581409Phase 4
• Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage ClosureActive, not recruitingNCT03568890Phase 4
• A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male SubjectsCompletedNCT03496506Phase 1
• Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical TherapyCompletedNCT03463317Phase 4
• Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients TrialCompletedNCT03431142Phase 4
• A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy SubjectsCompletedNCT03430661Phase 1
• Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on ClopidogrelCompletedNCT03392051Phase 1
• Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke PatientsCompletedNCT03385538Phase 4
• TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.CompletedNCT03357874Phase 3
• Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mgCompletedNCT03329261Phase 4
• Clopidogrel Prevention of Early Arteriovenous (AV) Fistula ThrombosisCompletedNCT03289520Phase 3
• A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)TerminatedNCT03224923Phase 4
• Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKDStatus unknownNCT03150667Phase 4
• Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.Status unknownNCT03103685Phase 4
• Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting StentsCompletedNCT03056118Phase 4
• Impact of Antiretroviral Treatment on Pharmacokinetics and Pharmacodynamics of Thienopyridines in Healthy Volunteers and HIV PatientsTerminatedNCT03054207Phase 1
• Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or TicagrelorCompletedNCT03039205Phase 2
• Different Dosage of Domestic and Imported Clopidogrel on the Platelet Inhibition Ratio in Patients Undergoing PCIStatus unknownNCT03006835Phase 4
• A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVICompletedNCT02989558Phase 3
• Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic EventsCompletedNCT02939872Phase 4
• Migraine Prophylaxis With Clopidogrel TrialStatus unknownNCT02938182Phase 4
• Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult VolunteersCompletedNCT02922465Phase 1
• Antiplatelet Therapy in Acute Mild-Moderate Ischemic StrokeCompletedNCT02869009Phase 3
• Clopidogrel for Acute Ischaemia of Recent OnsetCompletedNCT02776540Phase 4
• The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)CompletedNCT02767401Phase 4
• COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome TrialsWithdrawnNCT02723981Phase 4
• Genotyping Influences Outcome of Coronary Artery StentingCompletedNCT02707445Not applicable
• High On-treatment Platelet Reactivity Identified by Multiple Platelet Function AssayCompletedNCT02699008Not applicable
• Comparison Between Effect of Enoxaparin and Clopidogrel on Improving Pregnancy Rate in ICSIStatus unknownNCT02696330Phase 4
• A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial InfarctionCompletedNCT02663713Phase 4
• Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVICompletedNCT02640794Phase 4
• Patent Versus Generic Clopidogrel in Acute Coronary SyndromeStatus unknownNCT02628587Phase 4
• The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and InflammationWithdrawnNCT02626169Phase 4
• Zainidip in Renal Artery StenosisCompletedNCT02594410Phase 4
• The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic TreatmentCompletedNCT02580149Phase 4
• Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy SubjectsCompletedNCT02560688Phase 1
• Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent ImplantationTerminatedNCT02494284Phase 4
• Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)Status unknownNCT02457130Phase 4
• Plasma and Platelet microRNAs in Clopidogrel Low Response PatientsStatus unknownNCT02447809Phase 4
• Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary SyndromeStatus unknownNCT02446730Phase 4
• CV004-007 Thrombosis Chamber StudyCompletedNCT02439190Phase 1
• Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular RevascularizationWithdrawnNCT02433587Phase 3
• A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' StudyCompletedNCT02429271Phase 3
• Role of Immune Responses After Acute Myocardial InfarctionStatus unknownNCT02428374Phase 4
• Dose-escalation, Repeated and Single Oral Dosing StudyTerminatedNCT02419820Phase 1
• The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral InfarctionStatus unknownNCT02411903Phase 4
• Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With ChemotherapyTerminatedNCT02404363Phase 3
• Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and DefibrillatorStatus unknownNCT02331511Not applicable
• Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk ElderlyCompletedNCT02317198Phase 4
• Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtientsWithdrawnNCT02302508Phase 4
• Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological ThrombolysisCompletedNCT02298088Phase 3
• High "on Treatment" Platelet Reactivity in the Intensive Care UnitStatus unknownNCT02285751Phase 2
• Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male SubjectsCompletedNCT02265289Phase 1
• Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female SubjectsCompletedNCT02262650Phase 1
• Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve ImplantationCompletedNCT02247128Phase 4
• Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted CoilingStatus unknownNCT02224131Phase 4
• Influence of Clopidogrel on the Pharmacodynamics and Safety of Terbogrel in Healthy Male SubjectsCompletedNCT02222987Phase 1
• Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"CompletedNCT02206815Phase 4
• ONSET and OFFSET of Ticagrelor in ESRDCompletedNCT02163954Phase 3
• Optical Coherence Tomography to Evaluate Ticagrelor and ClopidogrelCompletedNCT02140801Phase 4
• Clopidogrel And Ticagrelor in Healthy SubjectsCompletedNCT02086903Phase 3
• Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACSTerminatedNCT02071966Phase 4
• Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)CompletedNCT02060786Phase 4
• Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?CompletedNCT02054663Phase 4
• Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)CompletedNCT02044250Phase 4
• A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding RiskCompletedNCT02044146Phase 2/3
• Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial InfarctionCompletedNCT02026219Phase 4
• TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMICompletedNCT02018055Phase 4
• Ticagrelor Loading Dose Versus Clopidogrel Loading and Reloading With Ticagrelor.CompletedNCT01961856Phase 3
• Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes TrialCompletedNCT01959451Phase 4
• Effect of Clopidogrel on Allergen Challenge in AsthmaCompletedNCT01955512Phase 2
• OPTImal Management of Antithrombotic Agents: OPTIMA-2 TrialCompletedNCT01955200Phase 4
• Ticagrelor vs Clopidogrel Effect on MFR in CAD PopulationCompletedNCT01894789Phase 2/3
• Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an EvaluationCompletedNCT01860105Phase 1
• The Antiplatelet and Immune Response TrialCompletedNCT01846559Phase 4
• Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease PatientsCompletedNCT01830491Phase 4
• Efficacy and Safety Study of TicagrelorStatus unknownNCT01812330Phase 3
• Uninterrupted Clopidogrel Therapy Before Elective Colonoscopy Will Increase the Risk of Post-polypectomy BleedingCompletedNCT01806090Phase 4

← Clopidogrel overview